Filing Details

Accession Number:
0001209191-10-054139
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-10 12:27:35
Reporting Period:
2010-11-09
Filing Date:
2010-11-10
Accepted Time:
2010-11-10 12:27:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486333 William Cameron Lawrence 400 - 1001 West Broadway
Vancouver A1 V6H 4B1
Principal Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-09 650 $15.73 3,050 No 4 P Indirect RRSP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect RRSP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 475 Indirect Spouse RRSP